Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol

Matthew R. Sydes, Nicholas D. James, Malcolm D. Mason et al.|Annals of Oncology|2018

Cited by 252